Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nalmefene for suppression of fentanyl-induced cough during induction of general anesthesia
ChiCTR-IPR-17014118Phase 4Not yet recruiting
- Sponsor
- Zhongshan Hospital, Fudan University
- Start
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of nalmefene in cough (3 arms), sponsored by Zhongshan Hospital, Fudan University. Primary endpoint: Severity of cough. Planned start Oct 2017; status: not yet recruiting.
02
Drugs
nalmefene
03
Conditions
cough
Beyond the preview
Go deeper on ChiCTR-IPR-17014118.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17014118.